Fig. 7From: Trefoil factors peptide-3 is associated with residual invasive breast carcinoma following neoadjuvant chemotherapya Correlation between response to neoadjuvant therapy and expression of TFF3. b Correlation between TFF3 and BCl2 expression in breast carcinoma cases treated with neoadjuvant therapy. c Correlation between TFF3 and AKT1 expression in breast carcinoma cases treated with neoadjuvant therapy. d Correlation between TFF3 and NF Kappa-B expression in breast carcinoma cases treated with neoadjuvant therapyBack to article page